← Back to Search

Educational Program

HALT-AD for Dementia (HALT-AD Trial)

N/A

Waitlist Available

Led By Sarah Banks, PhD, ABPP-CN

Research Sponsored by Alzheimer's Disease Cooperative Study (ADCS)

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 4 months

Awards & highlights

No Placebo-Only Group

Summary

This trial tests the HALT-AD online program, which teaches people at risk of dementia about healthy habits like good sleep and diet. It offers personalized tips and group support to help them make these changes.

Eligible Conditions

Dementia
Alzheimer's Disease
Brain training

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 4 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~4 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Users' Engagement With the HALT-AD Online Platform by Measuring the Percentage of Participants Who Completed All Courses.

Users' Engagement With the HALT-AD Online Platform by Measuring the Total Amount of Time (in Minutes) Spent Per User on All Courses Combined

Secondary study objectives

Change From Baseline in Knowledge on the HALT-AD Knowledge Assessment Survey at 4 Months

Change From Baseline in Lifestyle Risk on the HALT-AD Lifestyle Risk Assessment Survey at 4 Months

Change From Baseline in Self-efficacy on the New General Self-Efficacy Scale (NGSE) at 4 Months.

Other study objectives

Acceptability Survey- Users' Acceptability of the HALT-AD Program Content

FOCUS Group Discussion- Qualitative Evaluation of the HALT-AD Program Content

Qualitative Evaluation of Participant Responses During the Focus Group Discussion Groups

+2 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: HALT-ADExperimental Treatment1 Intervention

HALT-AD is an online educational program designed to teach about dementia and lifestyle changes that can help preserve brain health and lower dementia risk. Participants complete online courses and engage in facilitated discussion groups.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

HALT-AD

2022

N/A

~20

Do I qualify?Apply below to find out